Cargando…
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in the general population. PFO has been associated with the paradoxical embolism causing cryptogenic stroke and systemic embolization. Results from clinical trials, meta-analyses, and position papers support percutan...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004032/ https://www.ncbi.nlm.nih.gov/pubmed/36902748 http://dx.doi.org/10.3390/jcm12051952 |
| _version_ | 1784904739343826944 |
|---|---|
| author | Lucà, Fabiana Pino, Paolo G. Parrini, Iris Di Fusco, Stefania Angela Ceravolo, Roberto Madeo, Andrea Leone, Angelo La Mair, Mark Benedetto, Francesco Antonio Riccio, Carmine Oliva, Fabrizio Colivicchi, Furio Gulizia, Michele Massimo Gelsomino, Sandro |
| author_facet | Lucà, Fabiana Pino, Paolo G. Parrini, Iris Di Fusco, Stefania Angela Ceravolo, Roberto Madeo, Andrea Leone, Angelo La Mair, Mark Benedetto, Francesco Antonio Riccio, Carmine Oliva, Fabrizio Colivicchi, Furio Gulizia, Michele Massimo Gelsomino, Sandro |
| author_sort | Lucà, Fabiana |
| collection | PubMed |
| description | Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in the general population. PFO has been associated with the paradoxical embolism causing cryptogenic stroke and systemic embolization. Results from clinical trials, meta-analyses, and position papers support percutaneous PFO device closure (PPFOC), especially if interatrial septal aneurysms coexist and in the presence of large shunts in young patients. Remarkably, accurately evaluating patients to refer to the closure strategy is extremely important. However, the selection of patients for PFO closure is still not so clear. The aim of this review is to update and clarify which patients should be considered for closure treatment. |
| format | Online Article Text |
| id | pubmed-10004032 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100040322023-03-11 Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management Lucà, Fabiana Pino, Paolo G. Parrini, Iris Di Fusco, Stefania Angela Ceravolo, Roberto Madeo, Andrea Leone, Angelo La Mair, Mark Benedetto, Francesco Antonio Riccio, Carmine Oliva, Fabrizio Colivicchi, Furio Gulizia, Michele Massimo Gelsomino, Sandro J Clin Med Review Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in the general population. PFO has been associated with the paradoxical embolism causing cryptogenic stroke and systemic embolization. Results from clinical trials, meta-analyses, and position papers support percutaneous PFO device closure (PPFOC), especially if interatrial septal aneurysms coexist and in the presence of large shunts in young patients. Remarkably, accurately evaluating patients to refer to the closure strategy is extremely important. However, the selection of patients for PFO closure is still not so clear. The aim of this review is to update and clarify which patients should be considered for closure treatment. MDPI 2023-03-01 /pmc/articles/PMC10004032/ /pubmed/36902748 http://dx.doi.org/10.3390/jcm12051952 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Review Lucà, Fabiana Pino, Paolo G. Parrini, Iris Di Fusco, Stefania Angela Ceravolo, Roberto Madeo, Andrea Leone, Angelo La Mair, Mark Benedetto, Francesco Antonio Riccio, Carmine Oliva, Fabrizio Colivicchi, Furio Gulizia, Michele Massimo Gelsomino, Sandro Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title | Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title_full | Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title_fullStr | Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title_full_unstemmed | Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title_short | Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management |
| title_sort | patent foramen ovale and cryptogenic stroke: integrated management |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004032/ https://www.ncbi.nlm.nih.gov/pubmed/36902748 http://dx.doi.org/10.3390/jcm12051952 |
| work_keys_str_mv | AT lucafabiana patentforamenovaleandcryptogenicstrokeintegratedmanagement AT pinopaolog patentforamenovaleandcryptogenicstrokeintegratedmanagement AT parriniiris patentforamenovaleandcryptogenicstrokeintegratedmanagement AT difuscostefaniaangela patentforamenovaleandcryptogenicstrokeintegratedmanagement AT ceravoloroberto patentforamenovaleandcryptogenicstrokeintegratedmanagement AT madeoandrea patentforamenovaleandcryptogenicstrokeintegratedmanagement AT leoneangelo patentforamenovaleandcryptogenicstrokeintegratedmanagement AT lamairmark patentforamenovaleandcryptogenicstrokeintegratedmanagement AT benedettofrancescoantonio patentforamenovaleandcryptogenicstrokeintegratedmanagement AT ricciocarmine patentforamenovaleandcryptogenicstrokeintegratedmanagement AT olivafabrizio patentforamenovaleandcryptogenicstrokeintegratedmanagement AT colivicchifurio patentforamenovaleandcryptogenicstrokeintegratedmanagement AT guliziamichelemassimo patentforamenovaleandcryptogenicstrokeintegratedmanagement AT gelsominosandro patentforamenovaleandcryptogenicstrokeintegratedmanagement |